229 related articles for article (PubMed ID: 16543369)
1. A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent.
Bruley C; Lyons V; Worsley AG; Wilde MD; Darlington GD; Morton NM; Seckl JR; Chapman KE
Endocrinology; 2006 Jun; 147(6):2879-85. PubMed ID: 16543369
[TBL] [Abstract][Full Text] [Related]
2. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
[TBL] [Abstract][Full Text] [Related]
6. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
[TBL] [Abstract][Full Text] [Related]
7. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in human fetal lung and regulation of its expression by interleukin-1beta and cortisol.
Yang Z; Zhu P; Guo C; Zhu X; Sun K
J Clin Endocrinol Metab; 2009 Jan; 94(1):306-13. PubMed ID: 18840637
[TBL] [Abstract][Full Text] [Related]
8. C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways.
Williams LJ; Lyons V; MacLeod I; Rajan V; Darlington GJ; Poli V; Seckl JR; Chapman KE
J Biol Chem; 2000 Sep; 275(39):30232-9. PubMed ID: 10906322
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
10. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
11. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
12. Generation of porcine fibroblasts overexpressing 11β-HSD1 with adipose tissue-specific aP2 promoter as a porcine model of metabolic syndrome.
Jung EM; An BS; Kim YK; Jeong YH; Hwang WS; Jeung EB
Mol Med Rep; 2013 Sep; 8(3):751-6. PubMed ID: 23864280
[TBL] [Abstract][Full Text] [Related]
13. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
[TBL] [Abstract][Full Text] [Related]
14. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
Wamil M; Seckl JR
Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
[TBL] [Abstract][Full Text] [Related]
16. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.
Arai N; Masuzaki H; Tanaka T; Ishii T; Yasue S; Kobayashi N; Tomita T; Noguchi M; Kusakabe T; Fujikura J; Ebihara K; Hirata M; Hosoda K; Hayashi T; Sawai H; Minokoshi Y; Nakao K
Endocrinology; 2007 Nov; 148(11):5268-77. PubMed ID: 17702848
[TBL] [Abstract][Full Text] [Related]
17. Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue.
Vara Prasad SS; Jeya Kumar SS; Kumar PU; Qadri SS; Vajreswari A
Lipids Health Dis; 2010 Oct; 9():111. PubMed ID: 20932307
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
19. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]